Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome-Reference-Cited by-同舟云学术

Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome

Published:2019-12-17 Issue:2 Volume:130 Page:686-698
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Bowen Caitlin J.^ORCID,Calderón Giadrosic Juan Francisco^ORCID,Burger Zachary,Rykiel Graham^ORCID,Davis Elaine C.,Helmers Mark R.^ORCID,Benke Kelly^ORCID,Gallo MacFarlane Elena^ORCID,Dietz Harry C.

Funder

National Institutes of Health

Howard Hughes Medical Institute

National Marfan Foundation

Ehlers Danlos Syndrome Network C.A.R.E.S. Foundation

EDS Today

Daskal Family Foundation

Alison Aldredge Family Foundation

DEFY Foundation

Natural Sciences and Engineering Research Council of Canada

Fulbright Chile

Fondecyt Grant

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/130730/files/pdf

Reference67 articles.

1. Clinical and Genetic Features of Ehlers–Danlos Syndrome Type IV, the Vascular Type

2. Survival is affected by mutation type and molecular mechanism in vascular Ehlers–Danlos syndrome (EDS type IV)

3. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes

4. Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers–Danlos syndrome

5. Pathophysiology of aortic aneurysm: insights from human genetics and mouse models

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic mechanisms in genetically defined Ehlers–Danlos syndromes;Trends in Molecular Medicine;2024-09

2. Myeloid-Specific Thrombospondin-1 Deficiency Exacerbates Aortic Rupture via Broad Suppression of Extracellular Matrix Proteins;2024-07-31

3. Current Evidence and Future Perspectives in the Medical Management of Vascular Ehlers–Danlos Syndrome: Focus on Vascular Prevention;Journal of Clinical Medicine;2024-07-21

4. Coding and Non-Coding Transcriptomic Landscape of Aortic Complications in Marfan Syndrome;International Journal of Molecular Sciences;2024-07-05

5. MEK inhibitors: a promising targeted therapy for cardiovascular disease;Frontiers in Cardiovascular Medicine;2024-07-01